235 E 42nd St, New York, New York, US. | Sector: Manufacturing | Exchange: NEW YORK STOCK EXCHANGE, INC. | Web: https://www.pfizer.com/
According to the market data, Pfizer Inc. (PFE) stock price is $37.17 and the 52 weeks low is $30.65, which means the Pfizer Inc. stock price is up 7.63% in the last 12 months.
Pfizer Inc. (PFE) Stock Price is not Trending currently as per the Weekly Chart, which means the price may range between specific high and low levels for the next few months, unless some significant changes take place in the market performance or news.
Technical Indicators are algorithms that are used mostly by Technical traders to predict the price action of a stock.
Based on our analysis of 16 technical indicators, 18.75% are indicating that PFE Stock price might rise further, 31.25% indicating that PFE Stock price might fall, and 50.00% are in a neutral position.
Based on these technical algorithms, overall PFE stock price has a Neutral Signal, which means the stock price has the potential to move either up or down, depending on the nature of consolidating market phase, since majority of indicators are providing a neutral signal.
Out of 26 Institutional Analysts, majority recommended PFE stock as On Hold. This means investors are recommended to hold their existing positions if any, otherwise, the recommendation is neither to buy nor sell at this stage. Since most investors and traders follow analyst ratings closely, this can be a potentially driving factor for the future stock price of Pfizer Inc..
High | Low | Average |
---|---|---|
$55.65 | $36.36 | $41.35 |
The average price target for PFE by Institutional Analysts is $41.35, which is 11.25% Upside from the current price. So according to the Institutional Analysts, PFE Stock might be a bit undervalued at this stage and there’s potential for upside.
However, although Institutional Analysts set their price targets after extensive research, they’re not always correct. After all, the market is mostly driven by investors speculation and emotion than just concrete numbers.
According to the news articles published last week, most journalists and bloggers talked positively about PFE, it shows that Pfizer Inc. had a 78.57% positive news coverage.
Positive news coverage usually affects short-term price of a stock, so this positive coverage provides an indication that PFE stock price may surge in the next few weeks.
Analyst | Recommendation | Action |
---|---|---|
SVB Leerink | Market Perform | Maintained |
DZ Bank | Buy | Upgraded |
SVB Leerink | Market Perform | Maintained |
Mizuho | Buy | Maintained |
Morgan Stanley | Equal-Weight | Maintained |
RBC Capital | Sector Perform | Downgraded |
Goldman Sachs | Neutral | Reiterated |
Bernstein | Market Perform | Initiated |
SVB Leerink | Market Perform | Maintained |
Truist Securities | Buy | Initiated |
Atlantic Equities | Neutral | Downgraded |
Berenberg | Hold | Initiated |
Morgan Stanley | Equal-Weight | Maintained |
UBS | Neutral | Maintained |
SVB Leerink | Market Perform | Maintained |
SVB Leerink | Market Perform | Initiated |
JP Morgan | Neutral | Maintained |
Barclays | Equal-Weight | Maintained |
Morgan Stanley | Equal-Weight | Maintained |
RBC Capital | Outperform | Maintained |
Barclays | Equal-Weight | Initiated |
Mizuho | Buy | Initiated |
RBC Capital | Outperform | Initiated |
DZ Bank | Hold | Upgraded |
Morgan Stanley | Equal-Weight | Maintained |
Morgan Stanley | Equal-Weight | Downgraded |
Bank of America | Neutral | Downgraded |
Bank of America | Buy | Maintained |
Credit Suisse | Outperform | Upgraded |
Argus | Outperform | Upgraded |
UBS | Neutral | Downgraded |
JP Morgan | Neutral | Downgraded |
Citigroup | Sell | Maintained |
BMO Capital | Market Perform | Downgraded |
Credit Suisse | Neutral | Maintained |
Morgan Stanley | Overweight | Maintained |
Barclays | Equal-Weight | Maintained |
Credit Suisse | Neutral | Maintained |
BMO Capital | Outperform | Maintained |
Bank of America | Buy | Maintained |
BMO Capital | Outperform | Maintained |
Barclays | Equal-Weight | Downgraded |
Morgan Stanley | Overweight | Maintained |
Leerink Swann | Market Perform | Maintained |
Credit Suisse | Neutral | Maintained |
Barclays | Overweight | Maintained |
BMO Capital | Outperform | Maintained |
Morgan Stanley | Overweight | Upgraded |
BMO Capital | Outperform | Upgraded |
Credit Suisse | Neutral | Maintained |
Citigroup | Sell | Downgraded |
Guggenheim | Neutral | Initiated |
Barclays | Overweight | Upgraded |
BMO Capital | Market Perform | Downgraded |
Argus | Hold | Downgraded |
Jefferies | Hold | Downgraded |
Jefferies | Buy | Maintained |
Jefferies | Buy | Maintained |
Jefferies | Buy | Maintained |
Jefferies | Buy | Maintained |
Jefferies | Buy | Maintained |
Berenberg | Hold | Initiated |
Credit Suisse | Outperform | Maintained |
Leerink Swann | Market Perform | Maintained |
Leerink Swann | Market Perform | Maintained |
Jefferies | Buy | Maintained |
Societe Generale | Hold | Initiated |
SunTrust Robinson Humphrey | Neutral | Maintained |
Argus | Buy | Maintained |
Jefferies | Buy | Maintained |
Atlantic Equities | Overweight | Initiated |
SunTrust Robinson Humphrey | Neutral | Upgraded |
Argus | Buy | Maintained |
Cowen & Co. | Outperform | Upgraded |
Morgan Stanley | Overweight | Upgraded |
Jefferies | Buy | Maintained |
PiperJaffray | Overweight | Initiated |
Jefferies | Overweight | Initiated |
JP Morgan | Overweight | Maintained |
Deutsche Bank | Buy | Maintained |
Jefferies | Buy | Maintained |
Deutsche Bank | Buy | Maintained |
Jefferies | Buy | Maintained |
JP Morgan | Overweight | Maintained |
Citigroup | Buy | Maintained |
BMO Capital | Outperform | Upgraded |
Deutsche Bank | Buy | Maintained |
Jefferies | Buy | Maintained |
Deutsche Bank | Buy | Initiated |
BMO Capital | Market Perform | Downgraded |
Jefferies | Buy | Maintained |
Barclays | Equal-Weight | Maintained |
Credit Suisse | Outperform | Maintained |
Credit Suisse | Outperform | Maintained |
Citigroup | Buy | Maintained |
Jefferies | Buy | Maintained |
Morgan Stanley | Overweight | Maintained |
SunTrust Robinson Humphrey | Reduce | Maintained |
Bank of America | Buy | Maintained |
Jefferies | Buy | Upgraded |
Atlantic Equities | Overweight | Maintained |
Cowen & Co. | Market Perform | Downgraded |
Morgan Stanley | Overweight | Maintained |
LBBW Research | Buy | Upgraded |
Credit Suisse | Outperform | Initiated |
Jefferies | Hold | Downgraded |
Standpoint Research | Sell | Downgraded |
Jefferies | Buy | Maintained |
SunTrust Robinson Humphrey | Initiated | |
BMO Capital | Outperform | Maintained |
Jefferies | Buy | Maintained |
Morgan Stanley | Overweight | Maintained |
Bank of America | Buy | Maintained |
UBS | Buy | Maintained |
JP Morgan | Overweight | Maintained |
Goldman Sachs | Buy | Maintained |
BMO Capital | Outperform | Maintained |
Hilliard Lyons | Long-Term Buy | Maintained |
BMO Capital | Outperform | Maintained |
Jefferies | Buy | Maintained |
JP Morgan | Overweight | Maintained |
Citigroup | Buy | Initiated |
Citigroup | Buy | Maintained |
MKM Partners | Neutral | Downgraded |
Jefferies | Buy | Maintained |
BMO Capital | Outperform | Maintained |
Barclays | Equal-Weight | Maintained |
Jefferies | Buy | Maintained |
Morgan Stanley | Overweight | Maintained |
Jefferies | Buy | Maintained |
Bank of America | Buy | Maintained |
Morgan Stanley | Overweight | Maintained |
Jefferies | Buy | Maintained |
ISI Group | Buy | Initiated |
Citigroup | Neutral | Maintained |
Goldman Sachs | Buy | Maintained |
Actual | Estimate | Date |
---|---|---|
$0.72 | $0.7210592 | 2020-09-30 |
The latest average Earning Per Share Estimate for Pfizer Inc. is $0.87, which is higher than PFE's last EPS, $0.72. This means that Analysts are expecting Pfizer Inc. to report higher earnings. This can drive share prices higher since the investors have positive sentiment about market performance of Pfizer Inc..
Actual | Estimate | Date |
---|---|---|
$0.72 | $0.7210592 | 2020-09-30 |
$0.78 | $0.670034 | 2020-06-30 |
$0.8 | $0.7417440000000001 | 2020-03-31 |
$0.55 | $0.582568 | 2019-12-31 |
$0.75 | $0.624382 | 2019-09-30 |
$0.8 | $0.7601260000000001 | 2019-06-30 |
$0.85 | $0.7587827 | 2019-03-31 |
$0.64 | $0.6387846 | 2018-12-31 |
$0.78 | $0.7537529000000001 | 2018-09-30 |
$0.81 | $0.7516521 | 2018-06-30 |
$0.77 | $0.7521773 | 2018-03-31 |
$0.62 | $0.5673877 | 2017-12-31 |
$0.67 | $0.6512682 | 2017-09-30 |
$0.67 | $0.6641356 | 2017-06-30 |
$0.69 | $0.6783867 | 2017-03-31 |
$0.47 | $0.5054444 | 2016-12-31 |
$0.61 | $0.6227256 | 2016-09-30 |
$0.64 | $0.6298865 | 2016-06-30 |
$0.67 | $0.5573382 | 2016-03-31 |
$0.53 | $0.5265432999999999 | 2015-12-31 |
$0.6 | $0.5115044 | 2015-09-30 |
$0.56 | $0.5198167 | 2015-06-30 |
$0.51 | $0.498435 | 2015-03-31 |
$0.54 | $0.5336335 | 2014-12-31 |
$0.57 | $0.5577624 | 2014-09-30 |
$0.58 | $0.5712155999999999 | 2014-06-30 |
$0.57 | $0.5582573000000001 | 2014-03-31 |
$0.56 | $0.5279977 | 2013-12-31 |
$0.58 | $0.5638729 | 2013-09-30 |
$0.56 | $0.5561767 | 2013-06-30 |
$0.54 | $0.5604288000000001 | 2013-03-31 |
$0.47 | $0.4462988 | 2012-12-31 |
$0.53 | $0.53025 | 2012-09-30 |
$0.62 | $0.5482886 | 2012-06-30 |
$0.58 | $0.5691653 | 2012-03-31 |
$0.5 | $0.47357889999999997 | 2011-12-31 |
$0.62 | $0.5608126 | 2011-09-30 |
$0.6 | $0.593375 | 2011-06-30 |
$0.6 | $0.5911429 | 2011-03-31 |
$0.47 | $0.4630042 | 2010-12-31 |
The analysts provide Buy, Sell or Hold ratings after extensive research of a companies financial reports, listening to conference calls and some of them even get in contact with upper management of the company to get an overall picture of operation.
Although institutional Analyst’s are not always correct, their ratings are followed by millions of traders around the world and they can heavily influence trading activities for a company.
As a retail investor, going through analyst ratings will instantly provide you an idea if the stock is worth buying. Top Analysts also provide their price targets. It’s a prediction of where the stock price might go based on their analysis.
The best way to analyze price targets is to combined average price targets of major analysts. If the average price target is much higher than the current price of the stock, then the probability of a stock going up is also high.
Technical Analysis refers to analyzing a stock's price over a period of time. In the financial market, past price patterns are one of the strongest indicators of an asset's future performance.
In easier terms, millions of traders use Live Charts to watch the stock prices, it is actually a single source of truth for most traders. When a stock's price reaches a significant price level/pattern in the chart, millions of traders take buy/sell positions from those levels.
As a regular investor, one of the easiest ways to check technical analysis of a stock is through Technical Indicators. Technical Indicators are programmed algorithms that monitor price changes in the Charts and indicate Buy/Sell based on market conditions.
Some Technical Indicators can be very powerful (e.g SMA) and some can be pretty useless. Stock research tools like iTradely heavily simplify the technical analysis process for the investors by showing Buy/Sell/Neutral ratings combined from 17 powerful technical indicators, all in one page.
EPS, or Earning Per Share, can tell a lot about a stock’s performance. It’s calculated by dividing a company’s profit by the number of outstanding shares of its common stocks.
In layman’s term, earnings is an indicator of a company’s profitability. Higher the earnings, the more profitable a company is.
Some traders pick stocks solely based on EPS or earnings Analysis, it is a very powerful indicator of a stock’s price.
Before you buy a stock, check the company’s earnings History and Surprises. A Surprise happens when a company reports a much higher or lower actual earnings/EPS than the forecasted earnings/EPS.
If a company reports higher EPS surprises consistently, analysts keep raising their estimates, traders become more confident in the company, driving the share price higher.
Stock Sentiment refers to how people speculating about the stock or what kind of trading position investors are often taking.
There are different kinds of sentiments you can find online for a company, this includes Investor Sentiment (Percentage of investors buying or selling), News Sentiment (Is the company getting positive or negative impressions from the Press?), Social Sentiment (The overall trends about the company in social media, is it negative or positive?).